Cleber Ribeiro
About Cleber Ribeiro
Cleber Ribeiro is an Analyst at Bristol-Myers Squibb in New Jersey, with over 17 years of experience in the pharmaceutical industry, including roles at Sanofi in France and Instituto Butantan in Brazil.
Current Role at Bristol-Myers Squibb
Cleber Ribeiro is currently employed as an Analyst at Bristol-Myers Squibb in New Jersey, United States. He has been with the company for over 8 years, joining the team in May 2015. In his role, he applies his extensive expertise in analytics to support various pharmaceutical projects and initiatives.
Previous Experience at Sanofi
Cleber Ribeiro previously worked at Sanofi as an Analyst in Aquitaine, France. His tenure at Sanofi lasted 8 years, from 2006 to 2014. During this period, Cleber contributed significantly to the company's operations, utilizing his analytical skills to improve various processes and outcomes within the organization.
Career at Instituto Butantan
Cleber Ribeiro has also been associated with Instituto Butantan in Brazil. His work at this prestigious research institute added to his broad experience in the pharmaceutical industry. Details about his specific roles and achievements at Instituto Butantan remain unspecified, but his tenure there is a key part of his professional background.
Educational Background
Cleber Ribeiro's academic credentials include studying at Uninove - Universidade Nove De Julho from 2002 to 2007. He also attended Instituto Butantan, where he likely engaged in specialized training or research activities, enhancing his knowledge and skills in the pharmaceutical field.
International Work Experience
Cleber Ribeiro's career is marked by international work experience, having held significant roles in Brazil, France, and the United States. This diverse background has equipped him with a global perspective and a deep understanding of the pharmaceutical industry across different regions. His ability to adapt and thrive in various cultural and professional environments is a testament to his versatility and commitment.